Plaintiffs involved in lawsuits over contamination of a key ingredient in generic heart medications have moved to have their cases consolidated before a federal judge.
Shipments of valsartan, an ingredient in medications used to treat high blood pressure and heart failure, were found to be tainted with a chemical known as NDMA. According to the EPA, NDMA is a possible human carcinogen and is used in ...
continue reading...